Early intensive treatment for HIV-infected infants to achieve remission
P1115 - VERY EARLY INTENSIVE TREATMENT OF HIV-INFECTED INFANTS TO ACHIEVE HIV REMISSION: A PHASE I/II PROOF OF CONCEPT STUDY
This study is looking at whether starting HIV treatment right after birth can help babies with HIV stay healthy and possibly even go into remission, and it’s open to infants, children, and teens who are living with the virus.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Westat, INC. NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project ID | NIH-11182832 on NIH RePORTER |
What this research studies
This research investigates the effects of very early and intensive antiretroviral therapy on infants infected with HIV. The study aims to determine if starting treatment shortly after birth can lead to HIV remission. It involves multiple clinical trial sites and focuses on infants, children, and adolescents, assessing the potential benefits of early intervention in managing HIV. Participants will receive close monitoring and care as part of the trial.
Who could benefit from this research
Good fit: Ideal candidates for this research are infants diagnosed with HIV, particularly those under the age of 11.
Not a fit: Patients who are older than 11 years or those without an HIV diagnosis will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in achieving HIV remission in infants, potentially transforming their long-term health outcomes.
How similar studies have performed: Previous research has shown promise in early HIV treatment approaches, but this specific intensive treatment strategy is still being explored.
Where this research is happening
Rockville, United States
- Westat, INC. — Rockville, United States (Active)
Researchers
- Principal investigator: Driver, Barbara — Westat, INC.
- Study coordinator: Driver, Barbara
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.